CD8A and neoplasm: T cell-predominant models require different approaches, as T cell-engaging tumor organoid platforms showed enhanced CD8+ T cell activation with increased interferon-gamma (IFN-γ) and granzyme B (GZMB) expression when treated with epigenetic inhibitors [460].